Back to Search Start Over

Reply

Authors :
Andrés Íñiguez Romo
Antonio Tello-Montoliu
Victor Alfonso Jimenez Diaz
Ignacio Cruz Gonzalez
Raul Moreno
Source :
JACC: Cardiovascular Interventions. 12:803-804
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

We appreciate the insightful comments by Dr. Lozano and colleagues regarding our research. Although the link between high platelet reactivity (HPR) during P2Y12 inhibitors with stent thrombosis and mortality is clearly established, there is also an association between low platelet reactivity and

Subjects

Subjects :
medicine.medical_specialty
business.industry
Treatment outcome
030204 cardiovascular system & hematology
Platelet reactivity
03 medical and health sciences
0302 clinical medicine
P2Y12
Internal medicine
medicine
Cardiology
Platelet aggregation inhibitor
030212 general & internal medicine
Stent thrombosis
Cardiology and Cardiovascular Medicine
business

Details

ISSN :
19368798
Volume :
12
Database :
OpenAIRE
Journal :
JACC: Cardiovascular Interventions
Accession number :
edsair.doi...........fe0630898f320e12ded4c7ef73cfcd01

Tools

Authors Abstract Subjects Details